Walmart Invests $3.5 Billion in Flipkart and PhonePe to Prepare for IPO
#retail #ipos #strategy #ecommerce
2020 and 2021 saw an avalanche of US #IPOs when measured as proceeds raised and as number of listings, chart @JPMorganAM
Citi says more startups embracing ‘down round’ as private markets show signs of life amid IPO slump: ‘Boards have come around’
Come mai l'Integrated Palliative care Outcome Scale è diventato (vedi in fondo alla pagina) Integrated PATIENT care Outcome Scale?
Verrebbe quasi da pensare che a 13 anni dalla Legge 38 la parola "palliative" per alcuni sia ancora tabù.
Why did the Integrated Palliative care Outcome Scale become Integrated PATIENT care Outcome Scale? Is still the word "Palliative" a taboo for some?
Diamantes agora são oportunidades de investimento e têm até IPO
#Luxo #Ipos #Investimentos #Diamantes #Manchete #Forbeslife #ForbesMulher #ForbesMoney
#luxo #ipos #investimentos #diamantes #manchete #forbeslife #forbesmulher #forbesmoney
Busy with 3 program launches this year, Biogen trims pipeline —Novartis, helped by cost cuts, raises full-year outlook—Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO-- See more on our front page news http://bit.ly/w28kSd #earnings #biogen #novartis #jnj #consumerhealth #ipos #spinoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#earnings #biogen #novartis #jnj #consumerhealth #ipos #spinoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FDA rejects Teva’s high-potency biosimilar of Humira again — After a record run, fewer biotechs are going public— Sarepta shares drop as report says FDA almost rejected under-review gene therapy -- See more on our front page news http://bit.ly/w28kSd #tevapharma #fda #humira #abbvie #biosimilars #ipos #genetherapy #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#tevapharma #FdA #humira #abbvie #biosimilars #ipos #genetherapy #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
First batch of registration-based #IPOs start trading on main boards of #Shanghai, #Shenzhen bourses
The move signifies that China has applied the registration-based IPO system across the board, providing solid institutional support for accelerating the building of a standardized, transparent, open, dynamic and resilient capital market.
https://xhnewsapi.xinhuaxmt.com/share/news_pc?id=810707847766016&showType=3002
First batch of registration-based #IPOs start trading on main boards of #Shanghai, #Shenzhen bourses https://xhnewsapi.xinhuaxmt.com/share/news?id=810707847766016&showType=3002&utdId=0&version=3.1.3
Medtronic growth catalysts for 2023— After a standout IPO and series of pivots, Rubius closes its doors —Biotech entrepreneur Vivek Ramaswamy official launches 2024 presidential bid-- See more on our front page news http://bit.ly/w28kSd #medtronic #medtech #ipos #vivekramaswamy #2024election #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#Medtronic #medtech #ipos #vivekramaswamy #2024election #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Interesting...
---
RT @holgermu
.@BMCSoftware reportedly files plans for IPO that could value it at $15B https://bit.ly/3Koh8xj @SiliconANGLE @Mike_Wheatley “It would be an uncharacteristically short holding time for KKR, as it’s just five years since it took over the company…” >> good to see #IPOs back.
https://twitter.com/holgermu/status/1628119875217502213
CNBF Daily Brief 15.2.2023 – #China #SMEs activity, Outstanding #loans by Chinese banks to small and micro businesses, China's #machinery industry, Initial public offerings (#IPOs) of Technology, Media and Telecommunications (#TMT) companies: https://cnbusinessforum.com/cnbf-daily-brief-15-2-2023/
#china #smes #loans #machinery #ipos #tmt
Wired: Alphabet's Layoffs Aren’t Very Googley https://www.wired.com/story/plaintext-alphabets-layoffs-arent-very-googley/ #Tech #wired #TechNews #IT #Technology via @morganeogerbc #Business/TechCulture #SiliconValley #Plaintext #Business #Google #Search #Jobs #IPOs
#Tech #wired #technews #it #technology #business #siliconvalley #plaintext #google #search #jobs #ipos
Wired: Quantum Startups’ Stock Market Dreams Are Decohering https://www.wired.com/story/quantum-startups-stock-market-dreams-are-decohering/ #Tech #wired #TechNews #IT #Technology via @morganeogerbc #AutonomousVehicles #Business/Startups #quantumcomputing #VentureCapital #SiliconValley #FlawsofNature #StockMarket #Business #Finance #markets #IPOs
#Tech #wired #technews #it #technology #AutonomousVehicles #business #quantumcomputing #venturecapital #siliconvalley #flawsofnature #stockmarket #finance #markets #ipos
IPOs fail to bounce back in Q4 — FDA starts review of Sanofi, AZ antibody for RSV prevention — What Goldman Sachs got wrong about Medtronic in 2022 -- See more on our front page news http://bit.ly/w28kSd #ipos #fda #sanofi #astrazeneca #rsv #goldmansachs #medtronic #medicaldevices #medtech #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#ipos #FdA #Sanofi #astrazeneca #RSV #goldmansachs #Medtronic #medicaldevices #medtech #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
New proposal to create an International Panel for #ocean #sustainability (IPOS).
(1) Why is the #cfs High Level Panel of Experts on Food Security and Nutrition (HLPE) consistently left out of proposals of “an #ipcc for ___”? There’s a lot to learn from there.
(2) If the #ipos increases transparency and participation in ocean governance, I’m all for it. This means transdisciplinary and inclusive approaches must be central to the panel’s work.
#ipos #ipcc #cfs #sustainability #ocean
Next was a nice #TechCabal discussion on African #IPOs and #tech M&A with Juliet Anammah, Victor Basta, and Yewande Senbore. The relatively smaller capital markets on the African continent mean larger tech companies need to think differently about how to proceed to the next stage of growth, and the discussion here gets at how to think about that strategy and the governance processes that need to be in place https://www.youtube.com/watch?v=W-IALKT3sHc (6/10)
GSK to pull blood cancer drug from US market after study failure — Health tech companies weigh funding options amid weak IPO market —Cancer drugmaker Plexxikon gets new life as Opna Bio -- See more on our front page news http://bit.ly/w28kSd #gsk #multiplemyeloma #medtech #funding #ipos #cancer #rebranding #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#gsk #multiplemyeloma #medtech #funding #ipos #cancer #rebranding #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma